Richard Sheer, BA

Articles by Richard Sheer, BA

Activation, Physical Activity, and Outcomes Among Individuals With T2D

ByRadhika Nair, PhD,Eric Meadows, PhD,Richard Sheer, BA,Ilya Lipkovich, PhD,Jiat-Ling Poon, PhD,Zhenxiang Zhao, PhD,Brian Benneyworth, MD,Margaret Pasquale, PhD

August 9th 2022

This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.

Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes

ByEleanor O. Caplan, PhD,Richard Sheer, BA,Niklas Schmedt, DrPH,Thomas Evers, PhD,Meghan Cockrell, MPH,Michael Tindal, PharmD, MBA,Margaret K. Pasquale, PhD,Csaba P. Kovesdy, MD

May 11th 2021

Incidence of Gastrointestinal Events Among Bisphosphonate Patients in an Observational Setting

ByRedonda G. Miller, MD,Michael Bolognese, MD,Karen Worley, PhD,Amy Solis, BS,Richard Sheer, BA

August 1st 2004

Latest Updated Articles

Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes
May 11th 2021
Activation, Physical Activity, and Outcomes Among Individuals With T2D
August 9th 2022
Incidence of Gastrointestinal Events Among Bisphosphonate Patients in an Observational Setting
August 1st 2004

Richard Sheer, BA

Articles by Richard Sheer, BA

Activation, Physical Activity, and Outcomes Among Individuals With T2D

Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes

Incidence of Gastrointestinal Events Among Bisphosphonate Patients in an Observational Setting

Latest Updated Articles

Trending on AJMC

5 FAQs: Ebola Outbreaks and the Challenge of Public Trust

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox

How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap

Tisagenlecleucel Yields Promising Disease-Free Survival in High-Risk Pediatric ALL: Shannon L. Maude, MD, PhD

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications